We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...
Primrose Bio announced a new product to improve the manufacturing on long-template mRNA vaccines. 1 The Prima RNApols ExTend ...
European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 ...
Ottawa Citizen on MSN10hOpinion
Deonandan: Canada should act quickly to attract U.S. scientists fleeing TrumpSince taking office in January, the Trump administration has eliminated thousands of positions in major public health and ...
The New Republic on MSN16hOpinion
Trump’s Atrocious War on Higher Ed Demands an Aggressive ResponseAmerica’s colleges and universities enrich everyone in ways that aren’t often acknowledged. It’s high time to remind ...
Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...
Psychiatric disorders challenge us deeply. At the University of Arizona, researchers dissect their molecular roots, focusing ...
DeepIP, the AI-powered patent assistant, has secured $15 million in Series A funding to modernize the outdated patent filing ...
Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...
Results for the Year Ended December 31, 2024 Revenue reached RMB1,986.7 million Gross profit amounted to RMB687.4 million Net profit recorded RMB222.0 ...
Trump’s auto tariffs are here and the sector doesn’t look ready, gold card visas may have a tax problem, and more news to ...
What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback